×
About 6,583 results

ALLMedicine™ Herpes Zoster Center

Research & Reviews  1,729 results

Improving Shingles Vaccination Rates in Family Medicine.
https://doi.org/10.12788/jfp.0218
The Journal of Family Practice; Luther JS

Aug 26th, 2021 - At the end of the activity, participants will be able to: • Characterize the burden of herpes zoster infections. • Recommend the recombinant zoster vaccine to patients in accordance with guidance from the Advisory Committee on Immunization Practic...

Equivalent Cellular and Humoral Immunity to Varicella-Zoster Virus in Patients With Inf...
https://doi.org/10.14309/ctg.0000000000000446
Clinical and Translational Gastroenterology; Caldera F, Wald A et. al.

Jan 22nd, 2022 - Patients with inflammatory bowel disease (IBD) are at increased risk for herpes zoster (HZ). HZ is caused by reactivation of the varicella zoster virus (VZV) and is prevented by strong VZV-specific cell mediated immunity. The aim of our study was ...

Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations ...
https://doi.org/10.1080/21645515.2022.2027196
Human Vaccines & Immunotherapeutics; Curran D, La EM et. al.

Jan 21st, 2022 - Due to COVID-19, vaccinations dropped in 2020 and 2021. We estimated the impact of reduced recombinant zoster vaccine (RZV) use on herpes zoster (HZ) cases, complications, and quality-adjusted life-year (QALY) losses among older adults. Various sc...

Shingrix in Renal Transplant Recipients
https://clinicaltrials.gov/ct2/show/NCT04128189

Jan 20th, 2022 - Herpes Zoster (HZ) is a common complication of kidney transplant because of the immune suppressive drugs necessary to prepare the recipient for the transplanted organ and to protect it from rejection. The use of the live vaccine, Zostavax, in tran...

see more →

Guidelines  3 results

Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization ...
https://www.ncbi.nlm.nih.gov/pubmed/18528318
MMWR. Recommendations and Reports : Morbidity and Mortali... Harpaz R, Ortega-Sanchez IR et. al.

Jun 6th, 2008 - These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a live attenuated vaccine for the prevention of herpes zoster (zoster) (i.e., shingles) and its sequelae, which was licens...

Interventional management of neuropathic pain: NeuPSIG recommendations.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484720
Pain References; Dworkin RH, O'Connor AB et. al.

Jun 12th, 2013 - Neuropathic pain (NP) is often refractory to pharmacologic and noninterventional treatment. On behalf of the International Association for the Study of Pain Neuropathic Pain Special Interest Group, the authors evaluated systematic reviews, clinica...

Vaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidel...
https://www.ncbi.nlm.nih.gov/pubmed/22086887
The Journal of the American Osteopathic Association; Hendriksz T, Malouf P et. al.

Dec 7th, 2011 - Although vaccinations are most commonly associated with the pediatric population, it is important for healthcare professionals to be familiar with the vaccines that are recommended for adults. The authors discuss 3 vaccines-the measles, mumps, and...

see more →

Drugs  496 results see all →

Clinicaltrials.gov  41 results

Shingrix in Renal Transplant Recipients
https://clinicaltrials.gov/ct2/show/NCT04128189

Jan 20th, 2022 - Herpes Zoster (HZ) is a common complication of kidney transplant because of the immune suppressive drugs necessary to prepare the recipient for the transplanted organ and to protect it from rejection. The use of the live vaccine, Zostavax, in tran...

Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab
https://clinicaltrials.gov/ct2/show/NCT03798691

Jan 13th, 2022 - The purpose of this study is to determine the immunogenicity of the herpes zoster subunit vaccine in inflammatory bowel disease patients on vedolizumab compared to those on anti-tumor necrosis factor (TNF) monotherapy. The study will evaluate humo...

Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX)
https://clinicaltrials.gov/ct2/show/NCT05082688

Dec 8th, 2021 - Rationale: Vaccination of the older adults is often advised as they are a high-risk population; however, vaccine efficacy generally decreases with age. This is mainly due to a decrease in adaptive immune responses known as immunosenescence, which ...

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
https://clinicaltrials.gov/ct2/show/NCT02538341

Nov 23rd, 2021 - Herpes zoster (HZ), also known as "shingles", is caused by reactivation and multiplication of the ubiquitous varicella zoster virus (VZV) that remains latent in everyone's sensory neurons following varicella, or "chickenpox". Among individuals who...

A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of th...
https://clinicaltrials.gov/ct2/show/NCT04176939

Sep 13th, 2021 - The purpose of this study is to evaluate the long-term immune responses to the Herpes Zoster subunit (HZ/su) vaccine as well as safety up to 7 years after the 2-dose primary vaccination course from study ZOSTER-041 (NCT02058589). This study will a...

see more →

News  356 results

Herpes Zoster Vaccine Can Save Your Patients' Eyesight
https://www.medscape.com/viewarticle/966888

Jan 21st, 2022 - The first vaccine for shingles in the United States — Zostavax — was approved by the US Food and Drug Administration in 2006. The landmark study, published in the The New England Journal of Medicine in 2005, involved over 38,000 adults aged 60 yea...

Success for Upadacitinib in PsA, Despite Concerns
https://www.medpagetoday.com/rheumatology/arthritis/96405

Dec 28th, 2021 - On April 1, 2021, MedPage Today reported on a study on the successful treatment of psoriatic arthritis (PsA) with upadacitinib (Rinvoq), with 24 weeks of follow-up. As a review of the year's top stories, we follow up on what has happened since thi...

Herpes zoster events are common in tofacitinib-treated RA patients but are clinically manageable
https://www.mdedge.com/rheumatology/article/250243/rheumatoid-arthritis/herpes-zoster-events-are-common-tofacitinib-treated

Dec 25th, 2021 - Key clinical point: Herpes zoster (HZ) events occur in tofacitinib-treated patients with rheumatoid arthritis (RA), but most of them are nonserious, mild, or moderate with HZ events resolving in most patients. Major finding: Overall, 11.

Zosteriform Eruption on the Chest and Abdomen
https://www.mdedge.com/dermatology/article/250120/dermatopathology/zosteriform-eruption-chest-and-abdomen
Paola Batarseh, BS, Elizabeth Quigley, MD

Dec 20th, 2021 - THE DIAGNOSIS: Cutaneous Metastatic Mesothelioma Biopsies of the larger erythematous papules revealed an infiltrate of atypical tumor cells with mitoses (Figure 1) that were immunoreactive for calretinin (Figure 2) and lacked nuclear BRCA1 associa.

No Link Between mRNA COVID-19 Vaccinations and Shingles Flare-Ups: Study
https://www.medscape.com/viewarticle/964771

Dec 15th, 2021 - NEW YORK (Reuters Health) - New research helps dispel concerns that mRNA-based COVID-19 vaccination could be associated with an increased risk of herpes zoster reactivation. "There have been published case reports, as well as a lot of anecdotal re...

see more →

Patient Education  8 results see all →